Waisman Biomanufacturing

About Us

The UW Advantage

As our client you will gain a highly flexible and collaborative, yet industry-standard, contract development and manufacturing partnership with access to a dedicated project manager, scientific manufacturing and quality team leads, and an industry-experienced leadership team. In addition to our in-house facilities and equipment, you have the advantage of access to all that a leading research university has to offer. This is our Industry-Academia hybrid operational model. 

Opportunities are also available to collaborate with various UW groups that can help solve unique challenges that may be faced in advancing your product into clinical trials. Within our CGMP facility we have the capability of manufacturing your vaccine or therapy and simultaneously working with other groups at UW that can provide world-class expertise in key areas for drug development including: 

  • University of Wisconsin Biotechnology Center (http://www.biotech.wisc.edu) - Support for gene sequencing, LC-MS/MS, peptide mapping, gene expression analysis.
  • Lenor Zeeh Pharmaceutical Experiment Station (http://www.pharmacy.wisc.edu/zstation/) - Support for development of drug formulation and stability studies.
  • Waisman Center iPSC Core (https://www.waisman.wisc.edu/stem-cell-research-program/ipsc/) - Additional expertise to support clinical iPSC reprogramming in collaboration with Waisman Biomanufacturing.
  • University of Wisconsin Clinical Research Office (https://uwclinicaltrials.org) - Support for clinical researchers or industry partnerships to perform clinical trials. 
  • WiCell Research Institute (http://www.wicell.org/) - Support for stem cell culture techniques and new line derivation; cytogenetic analysis for release testing of pluripotent cell therapy products and cell banks.

Additional University of Wisconsin - Madison Links:

About Us